Exhibit 99.1

 

JOINT FILING AGREEMENT

 

     In accordance with Rule 13d-1(k)(1) promulgated under the Securities Exchange Act of 1934, the undersigned agree to the joint filing of a Statement on Schedule 13G (including any and all amendments thereto) with respect to the Common Stock, $0.0001 par value per share, of Journey Medical Corporation and further agree to the filing of this agreement as an exhibit thereto. In addition, each party to this Agreement expressly authorizes each other party to this Agreement to file on its behalf any and all amendments to such Statement on Schedule 13G. 

 

 

Date: November 29, 2024 TANG CAPITAL PARTNERS, LP
 
     
  By:   Tang Capital Management, LLC    
  Its:   General Partner   
     
  By:   /s/ Kevin Tang  
    Name:   Kevin Tang   
    Title:   Manager   
     
TANG CAPITAL PARTNERS III, INC
 
     
  By:   /s/ Kevin Tang  
    Name:   Kevin Tang   
    Title:   Chief Executive Officer  
         
TANG CAPITAL PARTNERS IV, INC
 
     
  By:   /s/ Kevin Tang  
    Name:   Kevin Tang   
    Title:   Chief Executive Officer  
 
  TANG CAPITAL MANAGEMENT, LLC
 
     
  By:   /s/ Kevin Tang  
    Name:   Kevin Tang   
    Title:   Manager   
     
  /s/ Kevin Tang  
  Name:   Kevin Tang